Aidea Pharma plans to launch a stock option incentive plan for 11.375 million shares
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Aidea Pharma disclosed its 2025 stock option incentive plan (draft), proposing to grant a total of 11.375 million stock options, accounting for approximately 2.703% of the company's total equity at the time of the announcement of the incentive plan draft. Among them, 9.1 million options will be granted initially, with a total of 45 individuals as the initial grantees, and the exercise price is set at 13.01 yuan per option
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments